Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 3,000 shares at $20.00 ($60K) on 2026-06-23, disclosed to the SEC on 2026-06-25.
Scheduled sale ($60k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GLUE | SELL | 2026-06-01 | $119K | — | Filing → |
| GLUE | SELL | 2026-01-05 | $48K | — | Filing → |